Silvant Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Silvant Capital Management LLC

  • $2.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019
SELL
$29.96 - $38.87 $167,056 - $216,739
-5,576 Closed
0 $0
Q4 2018

Feb 06, 2019
SELL
$30.84 - $49.51 $83,113 - $133,429
-2,695 Reduced 32.58%
5,576 $185,000
Q1 2018

May 09, 2018
BUY
$37.15 - $46.9 $307,267 - $387,909
8,271 New
8,271 $379,000

Others Institutions Holding SUPN

# of Institutions
281
Shares Held
60.6M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email